コンシェルジュ医療の世界市場：市場規模・シェア分析 (用途別 (プライマリケア、小児科、整体、内科、循環器科、精神科)・所有形態別 (単独、集団)・エンドユーザー別 (成人、小児))、産業の需要予測 (～2030年)

市場概要

世界のコンシェルジュ医療の市場規模は約171億米ドルです。しかし、この数字は2030年までに276億米ドルにまで上昇する見通しで、2024年から2030年までのCAGRは7.3%となっています。

このような業界の発展は、初期疾患診断に関する知識の増加、高齢者人口の増加、健康的でバランスの取れたライフスタイルを手に入れようとする個人の努力の増加によるものです。さらに、コンシェルジュ医療が提供するメリットは、医師の高額報酬と患者の待ち時間の短縮です。

主な洞察

2023年には、プライマリケアのカテゴリーが最大の業界シェアを握っています。その要因として、患者の意識が高まり、医師への即時アクセスや高度な医療サービスが提供されるからです。

コンシェルジュ医療は、個別化対応の医療サービスと医療提供者の不足により、高所得者の間で人気を集めています。

小児科は、予測期間中にCAGRが7.8%と最も高くなると予測されます。これは、小児科医が個々の患者、特に的を絞った診断と治療を必要とする新生児、乳児、幼児を治療する時間が増えるためです。

2023年には、グループカテゴリーが約60%のシェアで業界を支配します。

コンシェルジュ医療における単独経営 (開業医) は、予測期間中に急速に進むと予測されています。

当レポートでは、世界のコンシェルジュ医療の市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (金額ベース、2017～2030年)、用途別・所有形態別・エンドユーザー別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

• 市場力学
  • 動向
  • 促進要因
  • 抑制要因/課題
  • 促進要因/抑制要因の影響分析
• 新型コロナウイルス感染症 (COVID-19) の影響
• ポーターのファイブフォース分析

第6章 世界市場

• 概要
• 市場収益：用途別 (2017～2030年)
• 市場収益：所有形態別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)
• 市場収益：地域別 (2017～2030年)

第7章 北米市場

• 概要
• 市場収益：用途別 (2017～2030年)
• 市場収益：所有形態別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)
• 市場収益：国別 (2017～2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ市場

第12章 米国市場

• 概要
• 市場収益：用途別 (2017～2030年)
• 市場収益：所有構造別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

• 市場参入企業とその提供製品/サービスの一覧
• 主要企業の競合ベンチマーク
• 主要企業の製品ベンチマーク
• 最近の戦略展開状況

第30章 企業プロファイル

• Campbell Family Medicine
• Castle Connolly Private Health Partners LLC
• CONCIERGE CONSULTANTS & CARDIOLOGY
• MDVIP LLC
• PartnerMD
• PENINSULA DOCTOR
• Priority Physicians Inc.
• SignatureMD Inc.
• Specialdocs Consultants LLC

第31章 付録

Market Overview

The global concierge medicine market is around USD 17.1 billion. However, this figure is estimated to rise to USD 27.6 billion by 2030, which is equivalent to a 7.3% compound annual growth rate from 2024 to 2030.

This development of the industry can be credited to the increasing knowledge about initial disease diagnosis, the growing elderly populace, and the increasing efforts of individuals to attain a healthy and balanced lifestyle. Moreover, the benefits provided by concierge medicine comprise high recompenses for doctors and reduced waiting times for patients, which make this method common among both.

With the increasing use of telemedicine and tele health, the market picked up. Patients who have availed of concierge medicine services appreciate these technologies as they can schedule consultations with the physician as and when convenient. On the other hand, it replaces traveling that a patient would take to the doctor 's office.

This helps save patients time and money. Telemedicine applications provide high-resolution audio and video teleconferences, which enable easy access for patients to the physician from the comfort of their homes.

In addition to that, providers can manage the number of patients not showing up, since telemedicine could be utilized for this purpose. Thus, the convenience offered by such technologies has a positive impact on patient flow and increases the doctor's revenue.

Key Insights

In 2023, the primary care category grips the largest industry share because of augmented patient awareness, offering instant access to doctors and advanced-quality medicinal services.

For the patients the main advantage of primary care is that they receive longer, more comprehensive consultations, and get used to this setting, with the high patient volumes, to keep pace.

Concierge medicine is gaining popularity among high earners due to personalized healthcare services and the shortage of healthcare providers.

Paediatrics is projected to have the highest CAGR rate of 7.8% during the forecast period because pediatricians will have more time to treat each patient, especially neonates, infants, and toddlers who require targeted diagnosis and treatment.

In 2023, the group category dominates the industry with a share of approximately 60%.

The substantial existence of several top firms in the market offering these services is the major factor propelling the market.

Independent ownership in concierge medication is projected to advance quickly over the forecast period.

Independent practitioners see fewer patients every day in comparison to regular and group ownership models, leading to less workload, better compensation, and job satisfaction.

Rising awareness regarding physical well-being and the accuracy of healthcare boosts industry development.

Well-established healthcare infrastructure and favourable medical reimbursement policies contribute significantly to the region's dominance.

The global increase in the range of diseases of duration such as cancer, hyperglycaemia, and obesity is an issue that facilitates the development of precision medicine solutions.

The presence of a significant elderly population drives demand for immediate medical attention, supporting market growth.

The customization healthcare services, come with convenience and personalized care, thus attracting elderly patients and leading to the broadening of the market.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by application
  • 1.4.2. Market size breakdown, by ownership
  • 1.4.3. Market size breakdown, by end user
  • 1.4.4. Market size breakdown, by region
  • 1.4.5. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Application (2017-2030)
• 6.3. Market Revenue, by Ownership (2017-2030)
• 6.4. Market Revenue, by End User (2017-2030)
• 6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Application (2017-2030)
• 7.3. Market Revenue, by Ownership (2017-2030)
• 7.4. Market Revenue, by End User (2017-2030)
• 7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Application (2017-2030)
• 8.3. Market Revenue, by Ownership (2017-2030)
• 8.4. Market Revenue, by End User (2017-2030)
• 8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Application (2017-2030)
• 9.3. Market Revenue, by Ownership (2017-2030)
• 9.4. Market Revenue, by End User (2017-2030)
• 9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Application (2017-2030)
• 10.3. Market Revenue, by Ownership (2017-2030)
• 10.4. Market Revenue, by End User (2017-2030)
• 10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Application (2017-2030)
• 11.3. Market Revenue, by Ownership (2017-2030)
• 11.4. Market Revenue, by End User (2017-2030)
• 11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Application (2017-2030)
• 12.3. Market Revenue, by Ownership (2017-2030)
• 12.4. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Application (2017-2030)
• 13.3. Market Revenue, by Ownership (2017-2030)
• 13.4. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Application (2017-2030)
• 14.3. Market Revenue, by Ownership (2017-2030)
• 14.4. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Application (2017-2030)
• 15.3. Market Revenue, by Ownership (2017-2030)
• 15.4. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Application (2017-2030)
• 16.3. Market Revenue, by Ownership (2017-2030)
• 16.4. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Application (2017-2030)
• 17.3. Market Revenue, by Ownership (2017-2030)
• 17.4. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Application (2017-2030)
• 18.3. Market Revenue, by Ownership (2017-2030)
• 18.4. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Application (2017-2030)
• 19.3. Market Revenue, by Ownership (2017-2030)
• 19.4. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Application (2017-2030)
• 20.3. Market Revenue, by Ownership (2017-2030)
• 20.4. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Application (2017-2030)
• 21.3. Market Revenue, by Ownership (2017-2030)
• 21.4. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Application (2017-2030)
• 22.3. Market Revenue, by Ownership (2017-2030)
• 22.4. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Application (2017-2030)
• 23.3. Market Revenue, by Ownership (2017-2030)
• 23.4. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Application (2017-2030)
• 24.3. Market Revenue, by Ownership (2017-2030)
• 24.4. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Application (2017-2030)
• 25.3. Market Revenue, by Ownership (2017-2030)
• 25.4. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Application (2017-2030)
• 26.3. Market Revenue, by Ownership (2017-2030)
• 26.4. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Application (2017-2030)
• 27.3. Market Revenue, by Ownership (2017-2030)
• 27.4. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Application (2017-2030)
• 28.3. Market Revenue, by Ownership (2017-2030)
• 28.4. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Campbell Family Medicine
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Castle Connolly Private Health Partners LLC
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. CONCIERGE CONSULTANTS & CARDIOLOGY
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. MDVIP LLC
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. PartnerMD
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. PENINSULA DOCTOR
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Priority Physicians Inc.
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. SignatureMD Inc.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Specialdocs Consultants LLC
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports